NOW:53208:USA01012
http://widgets.journalinteractive.com/cache/JIResponseCacher.ashx?duration=5&url=http%3A%2F%2Fdata.wp.myweather.net%2FeWxII%2F%3Fdata%3D*USA01012
57°
H 61° L 57°
Clear | 0MPH

Enzyme Replacement Therapy Shows Promising Results in X-Linked Myotubular Myopathy

Jan. 24, 2013

A collaborative research team including a Medical College of Wisconsin (MCW) pediatric neuropathologist successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy from 4s3 Bioscience.

The findings are published in the January edition of Human and Molecular Genetics http://hmg.oxfordjournals.org/content/early/2013/01/09/hmg.ddt003.full.pdf+html.

X-linked myotubular myopathy (XLMTM) is a severe muscle disease caused by an absence of a protein called myotubularin. There is currently no treatment for this disorder, and most patients die in infancy or childhood. The overall incidence of myotubular myopathy is 1 in 50,000 live male births.

Michael W. Lawlor, MD, PhD, assistant professor of pathology at MCW, researcher at the Children’s Hospital of Wisconsin Research Institute, and director of the pediatric pathology neuromuscular laboratory in MCW’s division of pediatric pathology, coordinated a study at Boston Children’s Hospital and MCW that used targeted enzyme replacement therapy to deliver myotubularin to muscles of mice with XLMTM. After two weeks of treatment, the mice showed marked improvement in muscle function and pathology.

“These promising findings suggest that even low levels of myotubularin protein replacement can not only improve weakness in patients, but also at least partially reverse the structural abnormalities seen in XLMTM,” said Dr. Lawlor. “The next step is to determine appropriate dosage, and toxicity, before we venture into human trials,” he continued.

The study was supported by the National Institutes of Health, the Muscular Dystrophy Association, the Joshua Frase Foundation, and the Lee and Penny Anderson Family Foundation.

Co-authors of the study are Dustin Armstrong and Michael O’Callaghan from 4s3 Bioscience, Inc.; Marissa Viola, Cynthia P. Hsu, and Alan H. Beggs from Boston Children’s Hospital and Harvard Medical School; Jeffrey J. Widrick from Spaulding Rehabilitation Hospital; Hui Meng from MCW; Robert W. Grange from Virginia Tech; Martin Childers from Wake Forest University; Christopher R. Pierson from Nationwide Children’s Hospital; and Anna Buj-Bello from INSERM.

The efforts of Drs. Armstrong, Beggs, and Lawlor began while Dr. Lawlor was working for Dr. Beggs at Boston Children’s Hospital, and this collaborative effort has continued at Dr. Lawlor’s lab at MCW. As studies progress, Dr. Lawlor will continue to perform pathological analyses on research tissue from preclinical studies with the 4s3 Bioscience replacement enzyme and assist in further elucidating the pathophysiology of XLMTM. This work by Dr. Lawlor’s laboratory utilizes resources partially supported and available through the Children’s Research Institute’s Imaging Core Facility.

This site uses Facebook comments to make it easier for you to contribute. If you see a comment you would like to flag for spam or abuse, click the "x" in the upper right of it. By posting, you agree to our Terms of Use.

Suburban News Roundup

E-mail Newsletter

Your link to the biggest stories in the suburbs delivered Thursday mornings.


Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter
Get the Newsletter!

Login or Register to manage all your newsletter preferences.

Community Watch

» East kickers blank Tosa West, 2-0 5/2

» Investigation: Family behind collapsed Falls building has a history of neglecting properties Updated:  5/1

» Wauwatosa's Lady in Red reopens as Nikki's Boutique after remodel 4/30

» Exactly 175 years ago, Wauwatosa became a town 4/30

» Tosa Recreation Dept. to hold textile recycling event 4/29

» Wauwatosa parents ask Sen. Leah Vukmir to increase education funding 4/27

» Wauwatosa parents to ask Sen. Vukmir to restore education funding at forum tonight 4/27

» Foreign officials take inspiration from Wauwatosa's Innovation Campus 4/23

» Wauwatosa fire chief addresses threat of oil tanker derailment 4/22

» Mount Mary University students spruce up Wauwatosa business storefronts 4/22

» U-Haul moving into former Harley-Davidson plant in Wauwatosa 4/20

» Teen apparel store Garage coming to Mayfair 4/20

» Suburban Woman's Club of Wauwatosa awards scholarships to teachers 4/17

» Seniors now eligible for free Milwaukee County bus passes 4/16

» Irgens names Zywave as tenant for proposed office building in Wauwatosa 4/15

» Kmart closing in developing area of Wauwatosa 4/14

» Kmart in Wauwatosa will close 4/14

» UPDATE: Friday meeting will proceed without Rep. Kooyenga 4/14

» DOT resumes resurfacing work on Mayfair Road in Wauwatosa 4/13

» Diamond Stone headlines 2014-15 All-Suburban Boys Basketball team 4/13

» Wauwatosa now accepting electronic waste 4/9

» Tornado watch in effect 4/9

» Wauwatosa voters support Bradley, Cullen and state referendum 4/8

» Interactive: Test scores jump as Wauwatosa makes literacy a priority 4/8

» 2015 Milwaukee suburbs election roundup Updated:  4/8

View All Posts Got a tip? Welcome rss

Advertisement

Advertisement

Hidden Tosa

 

"Hidden Tosa" is a semi-regular feature where reporter Rory Linnane explores the closed down and closed off parts of Wauwatosa.

2015 Writing Contest

 

(Click image for details)


Local Business Directory

CONNECT